In 2009, two physician-researchers, Dr. Erwan L’Her (head of the intensive care unit and INSERM researcher at the University Hospital of Brest) and Dr. François Lellouche (intensivist and researcher at the QHLI) joined forces after a clinical research project to develop a device to automate the administration of oxygen therapy. They founded OxyNov Inc to focus entirely on developing the FreeO2 device, thus improving the application of this treatment on a daily basis.

OxyNov started up at the Quebec Heart and Lung Institute (QHLI) with the support of all pulmonologists. The team was aware of the daily challenge that applying the clinical recommendations represented for healthcare staff and firmly believed in the medical benefits of the solution.

Our mission is to overcome the current limitations of respiratory care and change clinical practice to improve the safety and quality of life of patients and optimize care in a context of an increasing number of patients and of hospitalization cost control. We are and will remain pioneers in oxygen therapy.